Comprehensive CMC Development Strategy for a Monoclonal Antibody Biosimilar

End-to-end CMC & regulatory plan

An integrated CMC strategy spanning cell line development, upstream and downstream process design, formulation, analytical comparability, and scale-up across dual filing pathways.